Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma, Hepatocellular × SHR-1701 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Hodgkin Disease 1 HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Bevacizumab 40 lenvatinib 33 atezolizumab 30 durvalumab 26 tremelimumab 22 sintilimab 13 pembrolizumab 13 Nivolumab 11 tislelizumab 10 Radiosurgery 10 camrelizumab 8 apatinib 8 Specimen Handling 8 Ipilimumab 7 Fluorouracil 7 Cyclophosphamide 7 regorafenib 6 cabozantinib 6 Radiotherapy 6 Oxaliplatin 6 Immune Checkpoint Inhibitors 6 fludarabine 5 Surgical Procedures, Operative 5 Sorafenib 5 Magnetic Resonance Spectroscopy 5 Leucovorin 5 Injections 5 Blood Specimen Collection 5 donafenib 4 Liver Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06893887 2025-07-02

ICT-HCC

Nanjing Tianyinshan Hospital

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡